Coherus BioSciences' low P/S ratio signals market worries ab...
Coherus BioSciences' low P/S ratio signals market worries about its weak future revenue growth. Investors may see this as an indication of potential struggles, influencing negative sentiment towards the stock.
Revenues Working Against Coherus BioSciences, Inc.'s (NASDAQ:CHRS) Share Price Following 28% Dive
免責聲明:以上信息不代表Moomoo Technologies Inc.("MTI")的任何立場,不構成與MTI及其關聯公司的任何投資建議。
更多信息
評論
登錄發表評論